Posted by Michael Wonder on 12 Jun 2019
How pharma could benefit from one of Congress’ signature drug pricing ideas
11 June 2019 - If you asked me in January whether Congress would stick it to pharma this Congress, I’d say the odds were pretty darn good.
Now I’m not only doubting Congress will inflict any pain on the industry, I’m starting to think the so-called reforms both Republicans and Democrats are pushing may leave the industry better off than when Congress gaveled in this January.
Hear me out: One of the big ideas Congress is talking about in earnest right now is capping what seniors can pay out of pocket each year at the pharmacy counter through Medicare Part D. (Need more of a policy primer on that? Keep reading, we’ve got a go-to guide this week on where things are in each congressional committee and which policies lawmakers are considering.)
